CD4+ T Helper Cell Activation via PADRE Epitope (N/A)

CD4+ T helper cell activation via the PADRE epitope is a process involving the recognition of the synthetic PADRE peptide presented on MHC class II molecules of antigen-presenting cells (APCs) by the T cell receptor (TCR) of CD4+ T cells. This interaction, along with co-stimulatory signals, leads to T cell activation, proliferation, and differentiation into various effector subtypes, ultimately contributing to the adaptive immune response. PADRE is designed for broad HLA-DR binding, enhancing CD4+ T cell activation across diverse populations and serving as an immunological adjuvant in vaccine development. It enhances both cellular and humoral immunity against target antigens.

Other names

PADRE-induced CD4+ T cell activationPan DR-binding epitope-mediated T cell activationMHC Class II-restricted T helper cell activation by PADRE

PADRE peptide binds to MHC Class II molecules on APCs, forming a complex recognized by the TCR on CD4+ T cells, leading to T cell activation, proliferation, and cytokine production. Co-stimulation via CD28/B7 is also required.